Exelixis Inc. Common Stock vs MACOM Technology — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while MACOM Technology trades at $330 (market cap $24.61B). The key difference: MACOM Technology is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, MACOM Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and MACOM Technology for 6 Days on average.
| EXEL | MTSI | |
|---|---|---|
Market Cap | $14.62B | $24.61B |
Volume | 2,684,957 | 1,594,575 |
Sector | Health | Technology |
52-Week High | $59.13 | $409.68 |
52-Week Low | $34.54 | $122.18 |
Typical Hold Time | 1 Days | 6 Days |
Enterprise Value | $13.95B | $24.32B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →